Targeted protein degradation: A promise for undruggable proteins

被引:168
作者
Samarasinghe, Kusal T. G. [1 ]
Crews, Craig M. [1 ,2 ,3 ]
机构
[1] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA
[2] Yale Univ, Dept Mol, New Haven, CT 06511 USA
[3] Yale Univ, Dept Pharmacol, New Haven, CT 06511 USA
关键词
CHEMICALLY-INDUCED DEGRADATION; TYROSINE KINASE ACTIVATION; BETA-CATENIN; SELECTIVE DEGRADATION; CHIMERIC MOLECULES; PROTAC DESIGN; CANCER; RESISTANCE; INHIBITORS; UBIQUITINATION;
D O I
10.1016/j.chembiol.2021.04.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein homeostasis, or "proteostasis," is indispensable for a balanced, healthy environment within the cell. However, when natural proteostasis mechanisms are overwhelmed from excessive loads of dysregulated proteins, their accumulation can lead to disease initiation and progression. Recently, the induced degradation of such disease-causing proteins by heterobifunctional molecules, i.e., PROteolysis TArgeting Chimeras (PROTACs), is emerging as a potential therapeutic modality. In the 2 decades since the PROTAC concept was proposed, several additional Targeted Protein Degradation (TPD) strategies have also been explored to target previously undruggable proteins, such as transcription factors. In this review, we discuss the progress and evolution of the TPD field, the breadth of the proteins targeted by PROTACs and the biological effects of their degradation.
引用
收藏
页码:934 / 951
页数:18
相关论文
共 183 条
[31]   Small-molecule targeted recruitment of a nuclease to cleave an oncogenic RNA in a mouse model of metastatic cancer [J].
Costales, Matthew G. ;
Aikawa, Haruo ;
Li, Yue ;
Childs-Disney, Jessica L. ;
Abegg, Daniel ;
Hoch, Dominic G. ;
Velagapudi, Sai Pradeep ;
Nakai, Yoshio ;
Khan, Tanya ;
Wang, Kye Won ;
Yildirim, Ilyas ;
Adibekian, Alexander ;
Wang, Eric T. ;
Disney, Matthew D. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (05) :2406-2411
[32]   Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1 [J].
Cotton, Adam D. ;
Nguyen, Duy P. ;
Gramespacher, Josef A. ;
Seiple, Ian B. ;
Wells, James A. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2021, 143 (02) :593-598
[33]   Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1 [J].
Crew, Andrew P. ;
Raina, Kanak ;
Dong, Hanqing ;
Qian, Yimin ;
Wang, Jing ;
Vigil, Dominico ;
Serebrenik, Yevgeniy V. ;
Hamman, Brian D. ;
Morgan, Alicia ;
Ferraro, Caterina ;
Siu, Kam ;
Neklesa, Taavi K. ;
Winkler, James D. ;
Coleman, Kevin G. ;
Crews, Craig M. .
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (02) :583-598
[34]   Targeting the Undruggable Proteome: The Small Molecules of My Dreams [J].
Crews, Craig M. .
CHEMISTRY & BIOLOGY, 2010, 17 (06) :551-555
[35]   Addressing Kinase-Independent Functions of Fak via PROTAC-Mediated Degradation [J].
Cromm, Philipp M. ;
Samarasinghe, Kusal T. G. ;
Hines, John ;
Crews, Craig M. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018, 140 (49) :17019-17026
[36]   Is β-Catenin a Druggable Target for Cancer Therapy? [J].
Cui, Can ;
Zhou, Xianglian ;
Zhang, Weidong ;
Qu, Yi ;
Ke, Xisong .
TRENDS IN BIOCHEMICAL SCIENCES, 2018, 43 (08) :623-634
[37]   Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer [J].
Cuneo, Kyle C. ;
Morgan, Meredith A. ;
Sahai, Vaibhav ;
Schipper, Matthew J. ;
Parsels, Leslie A. ;
Parsels, Joshua D. ;
Devasia, Theresa ;
Al-Hawaray, Mahmoud ;
Cho, Clifford S. ;
Nathan, Hari ;
Maybaum, Jonathan ;
Zalupski, Mark M. ;
Lawrence, Theodore S. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (29) :2643-+
[38]   Drugging the 'undruggable' cancer targets [J].
Dang, Chi V. ;
Reddy, E. Premkumar ;
Shokat, Kevan M. ;
Soucek, Laura .
NATURE REVIEWS CANCER, 2017, 17 (08) :502-508
[39]   Effects of pH and Salt Concentration on Stability of a Protein G Variant Using Coarse-Grained Models [J].
de Oliveira, Vinicius Martins ;
Contessoto, Vinicius de Godoi ;
da Silva, Fernando Bruno ;
Zago Caetano, Daniel Lucas ;
de Carvalho, Sidney Jurado ;
Pereira Leite, Vitor Barbanti .
BIOPHYSICAL JOURNAL, 2018, 114 (01) :65-75
[40]   BCL-2 is dispensable for thrombopoiesis and platelet survival [J].
Debrincat, M. A. ;
Pleines, I. ;
Lebois, M. ;
Lane, R. M. ;
Holmes, M. L. ;
Corbin, J. ;
Vandenberg, C. J. ;
Alexander, W. S. ;
Ng, A. P. ;
Strasser, A. ;
Bouillet, P. ;
Sola-Visner, M. ;
Kile, B. T. ;
Josefsson, E. C. .
CELL DEATH & DISEASE, 2015, 6 :e1721-e1721